Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer

Integrative Genomic Profiling of Human Prostate Cancer

Barry S. Taylor, Nikolaus Schultz, Haley Hieronymus et al. · Cancer Cell · 2010 · 3.7K citations · Full text

Urology, Functional Genomics, Integrative Genomic Profiling +5

Spred is a Sprouty-related suppressor of Ras signalling

Toru Wakioka, Atsuo T. Sasaki, Reiko Kato et al. · Nature · 2001 · 440 citations

Signal Transduction, Sprouty-related Suppressor, Gene Regulation +4

Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

J A Ruizeveld de Winter, P. J. A. Janssen, H M Sleddens et al. · PubMed · 1994 · 334 citations

Polycomb-Group Oncogenes EZH2, BMI1, and RING1 Are Overexpressed in Prostate Cancer With Adverse Pathologic and Clinical Features

Geert J.L.H. van Leenders, Danny F. Dukers, Daphne Hessels et al. · European Urology · 2006 · 179 citations

Oncogenic Agent, Medicine, Ring1 Are +9

Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

Takafumi Yoshida, Takao Hisamoto, Jun Akiba et al. · Oncogene · 2006 · 168 citations

Human Hepatocellular Carcinoma, Medicine, Ras/erk Signal Transduction +9